» Articles » PMID: 23091709

Management of Anemia of Inflammation in the Elderly

Overview
Journal Anemia
Publisher Wiley
Date 2012 Oct 24
PMID 23091709
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

Anemia of any degree is recognized as a significant independent contributor to morbidity, mortality, and frailty in elderly patients. Among the broad types of anemia in the elderly a peculiar role seems to be played by the anemia associated with chronic inflammation, which remains the most complex form of anemia to treat. The origin of this nonspecific inflammation in the elderly has not yet been clarified. It seems more plausible that the oxidative stress that accompanies ageing is the real cause of chronic inflammation of the elderly and that the same oxidative stress is actually a major cause of this anemia. The erythropoietic agents have the potential to play a therapeutic role in this patient population. Despite some promising results, rHuEPO does not have a specific indication for the treatment of anemia in the elderly. Moreover, concerns about their side effects have spurred the search for alternatives. Considering the etiopathogenetic mechanisms of anemia of inflammation in the elderly population, an integrated nutritional/dietetic approach with nutraceuticals that can manipulate oxidative stress and related inflammation may prevent the onset of this anemia and its negative impact on patients' performance and quality of life.

Citing Articles

Prevalence of Anemia in Patients With Rheumatoid Arthritis Presenting at Multi-organization Tertiary Care Hospitals.

Shah J, Farooq A, Zadran S, Kakar Z, Zarrar M, Bhatti H Cureus. 2024; 16(10):e72418.

PMID: 39588439 PMC: 11586881. DOI: 10.7759/cureus.72418.


Anemia and Its Connections to Inflammation in Older Adults: A Review.

Wacka E, Nicikowski J, Jarmuzek P, Zembron-Lacny A J Clin Med. 2024; 13(7).

PMID: 38610814 PMC: 11012269. DOI: 10.3390/jcm13072049.


Increased Serum Interleukin 10 Levels Are Associated with Increased Disease Activity and Increased Risk of Anti-SS-A/Ro Antibody Positivity in Patients with Systemic Lupus Erythematosus.

Winikajtis-Burzynska A, Brzosko M, Przepiera-Bedzak H Biomolecules. 2023; 13(6).

PMID: 37371554 PMC: 10296207. DOI: 10.3390/biom13060974.


Application of for Medicinal Purposes and the Food Industry: A Review of the Literature.

Gentscheva G, Nikolova K, Panayotova V, Peycheva K, Makedonski L, Slavov P Life (Basel). 2023; 13(3).

PMID: 36984000 PMC: 10058336. DOI: 10.3390/life13030845.


Emerging cellular senescence-centric understanding of immunological aging and its potential modulation through dietary bioactive components.

Sharma R, Diwan B, Sharma A, Witkowski J Biogerontology. 2022; 23(6):699-729.

PMID: 36261747 PMC: 9581456. DOI: 10.1007/s10522-022-09995-6.


References
1.
Woodman R, Ferrucci L, Guralnik J . Anemia in older adults. Curr Opin Hematol. 2005; 12(2):123-8. DOI: 10.1097/01.moh.0000154030.13020.85. View

2.
Xiao W, Koizumi K, Nishio M, Endo T, Osawa M, Fujimoto K . Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells. Exp Hematol. 2002; 30(11):1238-47. DOI: 10.1016/s0301-472x(02)00930-x. View

3.
Nemeth E, Tuttle M, Powelson J, Vaughn M, Donovan A, Ward D . Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004; 306(5704):2090-3. DOI: 10.1126/science.1104742. View

4.
Steinbicker A, Sachidanandan C, Vonner A, Yusuf R, Deng D, Lai C . Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. Blood. 2011; 117(18):4915-23. PMC: 3100698. DOI: 10.1182/blood-2010-10-313064. View

5.
Blagosklonny M . Aging: ROS or TOR. Cell Cycle. 2008; 7(21):3344-54. DOI: 10.4161/cc.7.21.6965. View